Polyrizon Ltd.(PLRZ)

Biotechnology · Ra'anana, TA

$9.21-0.05 (-0.54%)

Delayed quote: Oct 6, 2026, 12:47 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T16:52:50.451Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:52:50.451Z.

Quote observation: 2026-10-06T16:47:58.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: N/A
Quote market capitalization: 10,317,134

FMP input reference: 94b5ad3735cc71b9af2236876c301d5f64b1c42b83610b62f031870796dba4d5

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PLRZ Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

PLRZ Competitors' Operating Cash Flow Yield

PLRZ

Polyrizon Ltd.

Current

Market Cap

$10.32M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNTI

Senti Biosciences, Inc.

vs PLRZ

Market Cap

$10.31M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MSLE

Satellos Bioscience Inc.

vs PLRZ

Market Cap

$10.34M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs PLRZ

Market Cap

$10.52M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDCX

Medicus Pharma Ltd. Common Stock

vs PLRZ

Market Cap

$10.06M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs PLRZ

Market Cap

$10.61M

Operating Cash Flow Yield

N/A

TTM Avg

28.18%

3Y Avg

28.18%

5Y Avg

28.18%

LFWD

Lifeward Ltd.

vs PLRZ

Market Cap

$9.92M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs PLRZ

Market Cap

$10.96M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs PLRZ

Market Cap

$11.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIMD

Ainos, Inc.

vs PLRZ

Market Cap

$9.72M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Polyrizon Ltd. (PLRZ)	$10.32M	N/A	N/A	N/A	N/A
Senti Biosciences, Inc. (SNTI)vs ›	$10.31M	N/A	N/A	N/A	N/A
Satellos Bioscience Inc. (MSLE)vs ›	$10.34M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$10.52M	N/A	N/A	N/A	N/A
Medicus Pharma Ltd. Common Stock (MDCX)vs ›	$10.06M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.61M	N/A	28.18%	28.18%	28.18%
Lifeward Ltd. (LFWD)vs ›	$9.92M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.96M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.11M	N/A	N/A	N/A	N/A
Ainos, Inc. (AIMD)vs ›	$9.72M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

PLRZ Operating Cash Flow Yield Metrics

PLRZ Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics